A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: Further content: Find The Economist’s…
Professor Roger Seheult, MD discusses the Moderna COVID-19 mRNA vaccine: How it works and what we know about the safety, efficacy, and side effects at this time. No mRNA vaccine has ever been approved by the FDA, but Moderna and…
The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman…
Maryland researchers working on a potential coronavirus vaccine are excited by news Moderna announced Monday that their vaccine candidate is 94.5% effective at preventing infection. Last week, Pfizer announced its vaccine is 90% effective. Both findings are based on early…
Professor Roger Seheult, MD discusses the Pfizer COVID-19 mRNA vaccine: How it works and what we know about the safety and efficacy at this time. No mRNA vaccine has ever been approved by the FDA, but Pfizer and BioNTech hope…
Quarantined flight attendant Rochelle Crossley may be the first Australian to be immune from coronavirus after receiving a vaccine overseas. Subscribe: Get more breaking news at: Join 9News for the latest in news and events that affect you in your…
